Clinical Trial Update: Treatment of AMD With Rheohemapheresis /RHF/ [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating rheohemapheresis for age-related macular degeneration; current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Rheohemapheresis

Snippet

Sponsor: University Hospital Hradec Kralove | Conditions: Age Related Macular Degeneration | Phase 4 | Status: UNKNOWN